Home › NDC Lookup › RxCUI directory › RxCUI 198312

Triamterene 100 MG Oral Capsule — RxCUI 198312

Name: Triamterene 100 MG Oral Capsule (RxCUI 198312)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 198312 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198312

Official nameTriamterene 100 MG Oral Capsule

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped8

Package NDCs mapped10

Reported Medicaid activity (SDUD)1,245 prescriptions · 15 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Triamterene: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Triamterene is a water pill — more specifically, a 'potassium-sparing' diuretic. It's used to reduce fluid buildup (edema) caused by conditions like congestive heart failure, liver...
Taking triamterene capsules after meals helps reduce the chance of stomach upset like nausea or vomiting. It's a simple step that makes the medication easier to tolerate day to day...
It's a real concern worth taking seriously. Triamterene keeps potassium in your body, which is helpful — but if potassium climbs too high, it can cause dangerous heart rhythm probl...
I've heard this medication can raise my potassium too high — should I be worried?

📖 Read our full Triamterene guide →

🕸️ Concept Web — How Triamterene 100 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Triamterene 100 MG Oral Capsule RxCUI 198312 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Triamterene 10763 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Dyrenium 203238 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Triamterene Oral Capsule 374193 SCDF
- Triamterene Oral Product 1158234 SCDG
- Triamterene Pill 1158235 SCDG
- Triamterene Oral Capsule [Dyrenium] 366263 SBDF
- Dyrenium Oral Product 1170419 SBDG
- Dyrenium Pill 1170420 SBDG
- Oral Capsule 316965 DF
- Oral Product 1151131 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Triamterene 100 MG 316852 SCDC
- Triamterene 100 MG Oral Capsule [Dyrenium] 208674 SBD
- Triamterene 100 MG [Dyrenium] 569337 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Triamterene 100 MG SCDC · 316852
Triamterene Oral Capsule SCDF · 374193
Triamterene Oral Product SCDG · 1158234
Triamterene Pill SCDG · 1158235

Brand-Name Concepts

Triamterene 100 MG Oral Capsule [Dyrenium] SBD · 208674
Triamterene 100 MG [Dyrenium] SBDC · 569337
Triamterene Oral Capsule [Dyrenium] SBDF · 366263
Dyrenium Oral Product SBDG · 1170419
Dyrenium Pill SBDG · 1170420
Dyrenium BN · 203238

📦 FDA Products & Package NDCs

8 products · 10 package NDCs

10 package NDCs map to RxCUI 198312 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
52817-0364-10	100 CAPSULE in 1 BOTTLE (52817-364-10)	Triamterene	TRUPHARMA LLC	2018-12-12
52817-0365-10	100 CAPSULE in 1 BOTTLE (52817-365-10)	Triamterene	TRUPHARMA LLC	2018-12-12
59212-0002-01	100 CAPSULE in 1 BOTTLE (59212-002-01)	Dyrenium	Advanz Pharma (US) Corp.	1999-10-01
59212-0003-01	100 CAPSULE in 1 BOTTLE (59212-003-01)	Dyrenium	Advanz Pharma (US) Corp.	1999-01-01
66993-0831-02	100 CAPSULE in 1 BOTTLE (66993-831-02)	triamterene	Prasco Laboratories	2019-08-13
66993-0832-02	100 CAPSULE in 1 BOTTLE (66993-832-02)	Triamterene	Prasco Laboratories	2019-08-13
70377-0138-11	30 CAPSULE in 1 BOTTLE (70377-138-11)	Triamterene	Biocon Pharma Inc.	2025-02-10
70377-0138-12	100 CAPSULE in 1 BOTTLE (70377-138-12)	Triamterene	Biocon Pharma Inc.	2025-02-10
70377-0139-11	30 CAPSULE in 1 BOTTLE (70377-139-11)	Triamterene	Biocon Pharma Inc.	2025-02-10
70377-0139-12	100 CAPSULE in 1 BOTTLE (70377-139-12)	Triamterene	Biocon Pharma Inc.	2025-02-10

Observed labelers: Biocon Pharma Inc. (4) · Advanz Pharma (US) Corp. (2) · Prasco Laboratories (2) · TRUPHARMA LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.